Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lagares

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
The American Journal of Pathology|April 24, 2021
Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host MediatorsMichael O'Hare, Dhanesh Amarnani, Hannah A B Whitmore, et al.
The Journal of Pathology|October 24, 2025
Fibroblast-specific palladin drives kidney fibrosis via MRTF-SRF signalingNaoki Yamamoto, Norihiko Sakai, Yuta Yamamura, et al.
Nature Medicine|December 8, 2017
Corrigendum: ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosisDavid Lagares, Parisa Ghassemi-Kakroodi, Caroline Tremblay, et al.
Nature Medicine|October 24, 2017
ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosisDavid Lagares, Parisa Ghassemi-Kakroodi, Caroline Tremblay, et al.
Annals of the American Thoracic Society|October 30, 2023
Challenges and Opportunities for Commercializing Technologies in the Pulmonary Arena: An Official American Thoracic Society ReportMilica Vukmirovic, Kambez H Benam, Jason J Rose, et al.
Science Translational Medicine|November 1, 2019
Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosisAndrew J Haak, Enis Kostallari, Delphine Sicard, et al.
Science Translational Medicine|May 13, 2026
Natural killer cell immunotherapy reverses lung fibrosis by eliminating senescent fibroblastsWolfgang Merkt, Lea Rodon, Franca S Deicher, et al.
Nature Cell Biology|September 9, 2025
Durotaxis is a driver and potential therapeutic target in lung fibrosis and metastatic pancreatic cancerTaslim A Al-Hilal, Maria-Anna Chrysovergi, Paula E Grasberger, et al.
Cancer Research|February 2, 2021
Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic CancerAdam C Mueller, Miles Piper, Andrew Goodspeed, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
The American Journal of Pathology|April 24, 2021
Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host MediatorsMichael O'Hare, Dhanesh Amarnani, Hannah A B Whitmore, et al.
The Journal of Pathology|October 24, 2025
Fibroblast-specific palladin drives kidney fibrosis via MRTF-SRF signalingNaoki Yamamoto, Norihiko Sakai, Yuta Yamamura, et al.
Nature Medicine|December 8, 2017
Corrigendum: ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosisDavid Lagares, Parisa Ghassemi-Kakroodi, Caroline Tremblay, et al.
Nature Medicine|October 24, 2017
ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosisDavid Lagares, Parisa Ghassemi-Kakroodi, Caroline Tremblay, et al.
Annals of the American Thoracic Society|October 30, 2023
Challenges and Opportunities for Commercializing Technologies in the Pulmonary Arena: An Official American Thoracic Society ReportMilica Vukmirovic, Kambez H Benam, Jason J Rose, et al.
Science Translational Medicine|November 1, 2019
Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosisAndrew J Haak, Enis Kostallari, Delphine Sicard, et al.
Science Translational Medicine|May 13, 2026
Natural killer cell immunotherapy reverses lung fibrosis by eliminating senescent fibroblastsWolfgang Merkt, Lea Rodon, Franca S Deicher, et al.
Nature Cell Biology|September 9, 2025
Durotaxis is a driver and potential therapeutic target in lung fibrosis and metastatic pancreatic cancerTaslim A Al-Hilal, Maria-Anna Chrysovergi, Paula E Grasberger, et al.
Cancer Research|February 2, 2021
Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic CancerAdam C Mueller, Miles Piper, Andrew Goodspeed, et al.
Pageof 5